Comparing Adenoviruses and Adeno-Associated Viruses for Corneal Gene Therapy
Author Information
Author(s): Liu J., Saghizadeh M., Tuli S.S., Kramerov A.A., Lewin A.S., Bloom D.C., Hauswirth W.W., Castro M.G., Schultz G.S., Ljubimov A.V.
Primary Institution: University of Florida
Hypothesis
The study aims to compare the tropism of recombinant adenovirus (rAV) and recombinant adeno-associated virus (rAAV) constructs to different corneal cells.
Conclusion
rAAV can reach more corneal cells than rAV, especially keratocytes, but rAV may be more effective for applications requiring high protein expression levels.
Supporting Evidence
- rAV showed strong GFP signal in the epithelium with dose-dependent intensity.
- rAAV transduced epithelial, keratocytes, and endothelial cells, with more pronounced staining in basal epithelial cells with rAAV1.
- No difference in GFP expression patterns between normal and diabetic corneas was noted.
- Statistical analysis indicated rAAV1 produced significantly higher GFP expression than rAAV5.
Takeaway
This study looked at how well different viruses can deliver genes to corneal cells, finding that one type of virus is better at reaching more cells, while the other is better at making lots of proteins.
Methodology
The study used live rabbit and organ-cultured human corneas to compare the effectiveness of rAV and rAAV in delivering the GFP gene.
Limitations
The small sample size in the rabbit model may limit the generalizability of the findings.
Participant Demographics
The study included 16 healthy and diabetic postmortem human corneas.
Statistical Information
P-Value
0.007
Statistical Significance
p=0.007
Want to read the original?
Access the complete publication on the publisher's website